Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ensysce Biosciences Inc (NQ: ENSC )

0.6910 -0.0390 (-5.34%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ensysce Biosciences Inc

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Why Getaround Shares Are Trading Higher By Around 86%; Here Are 20 Stocks Moving Premarket
Shares of Getaround, Inc. (NYSE: GETR) rose sharply in pre-market trading after the company reported a year-over-year increase in third-quarter financial results. 
Via Benzinga
Ensysce Biosciences Announces Key Efficacy Data for Lead Analgesic
Via ACCESSWIRE
Ensysce Biosciences Discusses TAAP and MPAR(R) Applications and OncoZenge Partnership with The Stock Day Podcast
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Ensysce Biosciences Announces Completion of $1.7 Million Convertible Note Financing
Via ACCESSWIRE
Ensysce Biosciences and OncoZenge Announce Letter of Intent for the Co-development of BupiZenge(TM) in the United States
Via ACCESSWIRE
Ensysce Biosciences Announces Enrollment Completion for PF614-201 Clinical Study
Via ACCESSWIRE
Ensysce Biosciences Reports Third Quarter 2023 Financial Results
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire the company for $3.25 per share in cash. 
Via Benzinga
Ensysce Biosciences Secures $1.7 Million Convertible Note Financing
Via ACCESSWIRE
Ensysce Biosciences Announces Poster Presentation at the AAPS 2023 PharmSci 360
Via ACCESSWIRE
Ensysce Biosciences Releases "Highlights Video" of PAINWeek 2023 Symposium
Via ACCESSWIRE
Ensysce Biosciences to Chair the Fierce New Product Planning Summit 2023
Via ACCESSWIRE
Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
Why Netflix Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Gainers Nxu, Inc. (NASDAQ: NXU) shares surged 56.4% to $0.1079 in pre-market trading. On Oct. 17, Nxu received formal notice from Nasdaq staff that hearing is scheduled to be held on Dec. 14, 2023. 
Via Benzinga
Ensysce Biosciences Announces Completion of Site Initiation Visit for PF614-201 Clinical Study
Via ACCESSWIRE
Ensysce Biosciences to Host Research and Development FAQ Session Following PAINWeek Symposium on September 21, 2023
Via ACCESSWIRE
Ensysce Biosciences Completes Scale Up Manufacture of PF614 to Support Phase 3 Studies
Via ACCESSWIRE
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday. 
Via Benzinga
Ensysce Presents "A New Generation of Safer Pain Treatments"
Via ACCESSWIRE
Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Via ACCESSWIRE
Ensysce Biosciences to Present Clinical Dataset at Major PAINWeek Scientific Symposium
Via ACCESSWIRE
Ensysce Biosciences Reports Second Quarter 2023 Financial Results
Via ACCESSWIRE
Ensysce Biosciences Announces IRB Approval of Key Study Protocol
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Investors will want to get ready for another busy day of trading as we cover the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
Ensysce Biosciences Announces Engagement of Alacrita Consulting
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Ensysce Biosciences Stock Surged Today
Ensysce Biosciences, Inc. (NASDAQ: ENSC) shares popped Monday following positive coverage from HC Wainwright. The firm put a price target on the stock far above current levels. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.